FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
1,063 letters match. Newest first.
-
DrugsSklar Personal Care Inc.
Sklar Personal Care’s drug facility failed CGMP (current good manufacturing practice), including untested raw materials and inadequate cleaning, process validation, and quality oversight.
High risk -
Drugs3D Imaging Drug Design and Development LLC
FDA warns 3D Imaging of CGMP failures in sterile PET drug manufacturing and outdated drug listings.
High risk -
FoodHarbor Marine Product Inc.
FDA found Listeria bacteria on raw ready-to-eat fish contact surfaces and serious seafood HACCP and importer verification failures at Harbor Marine Product.
High risk -
OtherLongford Water Company LLC
FDA warns Longford Water Company that its bottled drinking water was made under insanitary conditions and without required treatment validation and testing.
High risk -
FoodTarget Corporation
FDA warns Target that recalled ByHeart infant formula tied to an infant botulism outbreak stayed on store shelves in 20 states.
High risk -
DrugsCatalent Indiana, LLC
Catalent Indiana's Bloomington plant released sterile vials contaminated with mammalian hair and failed to investigate, FDA says.
High risk -
DrugsSeaway Pharma Inc.
FDA cited Seaway Pharma for manufacturing-quality rule violations in OTC oral liquid drugs, including release and component-testing failures.
High risk -
DrugsDeVere Manufacturing Inc.
FDA warned DeVere Manufacturing in Janesville, Wisconsin, that its OTC hand sanitizers are adulterated after a June 2025 inspection found CGMP failures.
High risk -
DevicesEnvoy Medical Inc.
Envoy Medical in Saint Paul, MN was cited for quality system failures in making its Esteem II Implantable Hearing System, including slow complaint investigations and missed cleanroom contamination risks.
High risk -
FoodDelucas Bakery Corp
FDA warns Delucas Bakery Corp over unsanitary conditions, missing food safety plan, and undeclared allergens in ready-to-eat rolls and buns.
High risk -
DrugsRhyz Analytical Labs
FDA warned Rhyz Analytical Labs, a contract drug testing lab, that inadequate microbial failure investigations and quality oversight made tested drugs adulterated.
High risk -
DrugsPQ Pharmacy, LLC
FDA warns PQ Pharmacy, a Florida sterile drug compounder, that its products were made under unsafe conditions.
High risk -
DrugsTurbare Manufacturing
FDA warns outsourcing facility Turbare Manufacturing of Conway, Arkansas, for making sterile drugs under insanitary conditions.
High risk -
DrugsHandelnine Global, LLC dba Navafresh
Navafresh sells unapproved Ayurvedic drugs online, and its Rheumacare Capsules contain about 7,000 times the lead level of concern.
High risk -
DrugsWells Pharma of Houston, LLC
FDA warns Wells Pharma of Houston over sterile compounded drugs made under insanitary conditions.
High risk -
DrugsOwen Biosciences, Inc.
Owen Biosciences' over-the-counter benzoyl peroxide acne lotion had over 20 parts per million benzene and lacked release testing.
High risk -
DevicesHong Qiangxing Shenzhen Electronics Limited
FDA warned Hong Qiangxing Shenzhen Electronics after an inspection found quality-system violations in TENS, muscle stimulator, and blood pressure monitor manufacturing.
Medium -
DrugsShoplet
FDA warned Shoplet over website sales of unapproved, misbranded triclosan antiseptic lotion soaps.
Medium -
DrugsSave Rite Medical
Save Rite Medical sold triclosan antiseptic lotion soaps online as unapproved, misbranded new drugs.
Medium -
DrugsMedical Mega
FDA: Medical Mega sells unapproved triclosan antiseptic soaps as nonprescription drugs.
Medium -
DrugsSeema International
FDA warns Seema International over unclean API equipment, missing stability data, and quality-unit failures after inspection; APIs adulterated.
High risk -
DrugsSiddha Flower Essences, LLC., dba Siddha Remedies
FDA cites Siddha Remedies, a maker of children's homeopathic drugs, for untested water and botanicals and microbial contamination.
High risk -
DrugsWorld Perfumes Inc.
World Perfumes failed to test drug ingredients for toxic contaminants and had inadequate water, FDA says.
High risk -
DrugsDermaRite Industries, LLC
DermaRite failed CGMP and sold unapproved, misbranded OTC topical drugs, FDA says.
High risk -
DrugsUriel Pharmacy, Inc.
Uriel Pharmacy's homeopathic ampule drugs are unapproved new drugs and were made under serious CGMP violations.
High risk -
DrugsRNA Bio/Pharma, Incorporated
FDA found RNA Bio/Pharma failed to test homeopathic oral liquid drugs for dangerous contaminants and did not validate its water system.
High risk -
DrugsTaizhou Kangping Medical Science and Technology Co., Ltd.
FDA warns Taizhou Kangping about over-the-counter drugs labeled sterile that were not sterilized.
High risk -
FoodCompass Group USA
FDA found Listeria in Compass Group's Fresh & Ready Foods plant, tied to an outbreak that sickened ten and killed one.
High risk -
DrugsMaypharm
Maypharm website sells unapproved, misbranded Botulax botulinum toxin to U.S. consumers, FDA says.
High risk -
DrugsCelestaPro
FDA told CelestaPro its website sells unapproved, misbranded injectable botulinum toxin drugs, including "Nabota 200 Unit", to U.S. consumers.
High risk -
DrugsAceCosm
AceCosm’s website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers, FDA says.
High risk -
DrugsDermax Co., Ltd
FDA warned China's Dermax Co., Ltd. over its website selling unapproved, misbranded injectable botulinum toxin to U.S. consumers.
High risk -
DrugsCOSMO KOREA
FDA told South Korea's COSMO KOREA that its website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers.
High risk -
DrugsGlam Derma
FDA warns Glam Derma over website selling unapproved, misbranded injectable botulinum toxin products.
High risk -
DrugsMJS Medicals
FDA warned South Korea's MJS Medicals for selling unapproved, misbranded botulinum toxin ("Innotox") to U.S. consumers online.
High risk -
DrugsApotex Inc.
FDA cited Apotex's Richmond Hill sterile plant for failed investigations and aseptic contamination risks, prompting recalls.
High risk -
DrugsLiebel-Flarsheim Company LLC
Liebel-Flarsheim's Raleigh, NC sterile drug plant failed to investigate microbial and endotoxin test failures and let cleanrooms and equipment fall into disrepair.
High risk -
FoodEast Bay Wholesale Corporation
FDA says East Bay Wholesale lacked a Foreign Supplier Verification Program for imported banana, rice vermicelli, sweet corn.
Medium -
DrugsScientific Protein Laboratories, LLC
FDA warns Scientific Protein Laboratories over manufacturing failures in animal-derived APIs, including equipment particles and inadequate investigations.
High risk -
DrugsKath Khemicals LLC
FDA: Kath Khemicals, an OTC hand soap maker in Macomb, MI, released drugs without finished-product or glycerin identity testing.
High risk -
DrugsThe Tranzonic Companies/Innocore Sales & Marketing Inc.
FDA says Innocore Sales & Marketing, an over-the-counter drug manufacturer, lacked finished-product, component, stability and quality-unit controls.
High risk -
FoodV & L Produce, Inc.
V & L Produce lacked an FSVP for imported jalapeno peppers, green onions, and tomatillos, FDA says.
Medium -
DevicesQianjiang Kingphar Medical Material Co Ltd.
FDA warned Chinese device maker Qianjiang Kingphar that dirty cleanrooms and weak environmental controls make its masks, dressings, wraps and drapes adulterated.
High risk -
DrugsAcme United Corporation
Acme United Corporation made antiseptic wipes with contaminated water and released sterile drugs without sterility testing.
High risk -
DrugsHealth and Natural Beauty USA Corp.
FDA warns Health and Natural Beauty USA over CGMP failures and unapproved, misbranded SprinJene OTC toothpastes, including children’s products.
High risk -
DrugsNaturich Cosmetique Labs
FDA warned Naturich Cosmetique Labs over inadequate manufacturing controls for over-the-counter topical drugs, including contaminated water and untested ingredients.
High risk -
DrugsCreative Essences, Inc.
FDA warns Creative Essences over OTC drug manufacturing failures and an unapproved antiseptic.
High risk -
FoodAdja Khady Food Distribution Inc
New York food importer Adja Khady had no foreign supplier verification program for its imported foods, FDA says.
Medium -
FoodLife Wholesale
FDA says Life Wholesale, a Bronx importer, lacked required foreign supplier safety checks for three foods.
Medium -
FoodEver Rich Foods LLC
Ever Rich Foods LLC lacked a foreign supplier verification program for imported Indian sweets, FDA says.
Medium